What special considerations must be made for the pharmacotherapeutic management of heterozygous familial hypercholesterolemia?. (3rd July 2019)
- Record Type:
- Journal Article
- Title:
- What special considerations must be made for the pharmacotherapeutic management of heterozygous familial hypercholesterolemia?. (3rd July 2019)
- Main Title:
- What special considerations must be made for the pharmacotherapeutic management of heterozygous familial hypercholesterolemia?
- Authors:
- Polychronopoulos, Georgios
Tziomalos, Konstantinos - Abstract:
- Is Part Of:
- Expert opinion on pharmacotherapy. Volume 20:Number 10(2019)
- Journal:
- Expert opinion on pharmacotherapy
- Issue:
- Volume 20:Number 10(2019)
- Issue Display:
- Volume 20, Issue 10 (2019)
- Year:
- 2019
- Volume:
- 20
- Issue:
- 10
- Issue Sort Value:
- 2019-0020-0010-0000
- Page Start:
- 1175
- Page End:
- 1180
- Publication Date:
- 2019-07-03
- Subjects:
- Heterozygous familial hypercholesterolemia -- cardiovascular risk -- low-density lipoprotein cholesterol -- statins -- proprotein convertase subtilisin/kexin type 9 inhibitors -- ezetimibe -- mipomersen -- lomitapide
Chemotherapy -- Periodicals
615.5805 - Journal URLs:
- http://informahealthcare.com/ ↗
http://www.tandfonline.com/toc/ieop20/current ↗
http://informahealthcare.com ↗
http://titania.ashley-pub.com/vl=5663459/cl=52/nw=1/rpsv/journal/journal6_home.htm ↗ - DOI:
- 10.1080/14656566.2019.1598971 ↗
- Languages:
- English
- ISSNs:
- 1465-6566
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3842.002956
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 10866.xml